Sicong Tu1,2,3, Cristian E Leyton1,2,4, John R Hodges1,2,3, Olivier Piguet1,2,3, Michael Hornberger2,3,5. 1. Neuroscience Research Australia, Randwick, Sydney, Australia. 2. Australian Research Council Centre of Excellence in Cognition and its Disorders, Sydney, Australia. 3. School of Medical Sciences, University of New South Wales, Sydney, Australia. 4. Faculty of Health Sciences, University of Sydney, Sydney, Australia. 5. Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Abstract
BACKGROUND: Clinico-pathological distinction of primary progressive aphasia (PPA) can be challenging at clinic presentation. In particular, cross-sectional neuroimaging signatures across the logopenic (lvPPA) and semantic (svPPA) variants are difficult to establish, with longitudinal profiles showing greater divergence. OBJECTIVE: Assess longitudinal propagation of white matter degradation in lvPPA and svPPA to determine disease progression over time, and whether this reflects distinct underlying pathology. METHOD: A cohort of 27 patients with dementia (12 lvPPA; 15 svPPA) and 12 healthy controls were assessed at baseline and 1-year follow-up on the Addenbrooke's Cognitive Examination-Revised and Sydney Language Battery. Diffusion weighted images were collected at both time-points and analyzed for longitudinal white matter change using DTI-TK and TBSS. RESULTS: LvPPA patients showed a significant decline in naming and repetition, over 1 year, while svPPA patients declined in naming and comprehension. Longitudinal imaging revealed widespread bilateral degradation of white matter tracts in lvPPA over a 1-year period with early involvement of the left posterior inferior longitudinal fasciculus (ILF). SvPPA demonstrated focal left lateralized white matter degradation involving the uncinate fasciculus (UF) and anterior ILF, propagating to the right UF with disease progression. CONCLUSIONS: LvPPA and svPPA cohorts showed distinct longitudinal cognitive and white matter profiles. We propose differences in multi-centric and focal white matter dysfunction in lvPPA and svPPA, respectively, reflect underlying pathological differences. The clinical relevance of white matter degradation and mechanisms underlying disease propagation are discussed.
BACKGROUND: Clinico-pathological distinction of primary progressive aphasia (PPA) can be challenging at clinic presentation. In particular, cross-sectional neuroimaging signatures across the logopenic (lvPPA) and semantic (svPPA) variants are difficult to establish, with longitudinal profiles showing greater divergence. OBJECTIVE: Assess longitudinal propagation of white matter degradation in lvPPA and svPPA to determine disease progression over time, and whether this reflects distinct underlying pathology. METHOD: A cohort of 27 patients with dementia (12 lvPPA; 15 svPPA) and 12 healthy controls were assessed at baseline and 1-year follow-up on the Addenbrooke's Cognitive Examination-Revised and Sydney Language Battery. Diffusion weighted images were collected at both time-points and analyzed for longitudinal white matter change using DTI-TK and TBSS. RESULTS: LvPPA patients showed a significant decline in naming and repetition, over 1 year, while svPPA patients declined in naming and comprehension. Longitudinal imaging revealed widespread bilateral degradation of white matter tracts in lvPPA over a 1-year period with early involvement of the left posterior inferior longitudinal fasciculus (ILF). SvPPA demonstrated focal left lateralized white matter degradation involving the uncinate fasciculus (UF) and anterior ILF, propagating to the right UF with disease progression. CONCLUSIONS: LvPPA and svPPA cohorts showed distinct longitudinal cognitive and white matter profiles. We propose differences in multi-centric and focal white matter dysfunction in lvPPA and svPPA, respectively, reflect underlying pathological differences. The clinical relevance of white matter degradation and mechanisms underlying disease propagation are discussed.
Authors: Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind Journal: Semin Neurol Date: 2017-12-05 Impact factor: 3.420
Authors: Rene L Utianski; Hugo Botha; Jennifer L Whitwell; Peter R Martin; Christopher G Schwarz; Joseph R Duffy; Heather M Clark; Anthony J Spychalla; Matthew L Senjem; Ronald C Petersen; David S Knopman; Clifford R Jack; Val J Lowe; Keith A Josephs Journal: Neurobiol Aging Date: 2020-04-18 Impact factor: 4.673
Authors: Adam M Staffaroni; Peter A Ljubenkov; John Kornak; Yann Cobigo; Samir Datta; Gabe Marx; Samantha M Walters; Kevin Chiang; Nick Olney; Fanny M Elahi; David S Knopman; Bradford C Dickerson; Bradley F Boeve; Maria Luisa Gorno-Tempini; Salvatore Spina; Lea T Grinberg; William W Seeley; Bruce L Miller; Joel H Kramer; Adam L Boxer; Howard J Rosen Journal: Brain Date: 2019-02-01 Impact factor: 13.501
Authors: Fanny M Elahi; Gabe Marx; Yann Cobigo; Adam M Staffaroni; John Kornak; Duygu Tosun; Adam L Boxer; Joel H Kramer; Bruce L Miller; Howard J Rosen Journal: Neuroimage Clin Date: 2017-09-14 Impact factor: 4.881